Mackenzie Financial’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,116
Closed -$339K 1611
2023
Q2
$339K Buy
13,116
+3,276
+33% +$94.6K ﹤0.01% 1138
2023
Q1
$356K Buy
+9,840
New +$346K ﹤0.01% 1123
2021
Q4
Sell
-2,024
Closed -$236K 1517
2021
Q3
$236K Buy
+2,024
New +$265K ﹤0.01% 1238

Other funds holding NVRO

Mackenzie Financial's NVRO Position: Q3 2023 in Review

Mackenzie Financial sold out of NEVRO CORP. (NVRO) in Q3 2023, closing a stake of 13,116 shares — an estimated $339K sold.

Mackenzie Financial first reported a position in NVRO in Q3 2021 and held it in 3 quarters. The position peaked at $356K in Q1 2023. 136 funds tracked by Wall St. Rank hold NVRO as of Q3 2023.

  • Mackenzie Financial reported no remaining NEVRO CORP. position as of Q3 2023 after selling out during the quarter.
  • Mackenzie Financial sold 13,116 NEVRO CORP. shares in Q3 2023, an estimated $339K.
  • Mackenzie Financial first reported a position in NEVRO CORP. in Q3 2021 and held it in 3 quarters.
  • Mackenzie Financial's NEVRO CORP. position peaked at $356K in Q1 2023.
  • 136 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2023.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.